Ng-nitro-L-arginine, an NOS inhibitor, reduces tolerance to morphine in the rat locus coeruleus

Synapse

Volumn 29, Issue 3, 1998, Pages 233-239

  Highfield, D A ^a   Grant, S ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Brain slice; Extracellular; Nitric oxide; Noradrenaline; Single cell

Indexed keywords

MORPHINE; N(G) NITROARGININE; NITRIC OXIDE; NORADRENALIN;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN SLICE; DRUG TOLERANCE; ENZYME INHIBITION; HYPERACTIVITY; HYPERPOLARIZATION; IONTOPHORESIS; LOCUS CERULEUS; NONHUMAN; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; WITHDRAWAL SYNDROME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; ELECTROPHYSIOLOGY; ENZYME INHIBITORS; LOCUS COERULEUS; MORPHINE; NEURONS; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS;

EID: 0031806904     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199807)29:3<233::AID-SYN5>3.0.CO;2-7     Document Type: Article

References (49)

1. Adams, M.L., Kalicki, J.M., Meyer, E.R., and T.J. Cicero (1993) Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, Ng-nitro-L-arginine methyl ester. Life Sci., 52:245-249.
2. Aghajanian, G.K. (1978) Tolerance of locus coeruleus neurons to morphine and suppression of opiate withdrawal response by clonidine. Nature, 276:186-188.
3. Aghajanian, G.K., and Rasmussen, K. (1989) Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motorneurons in adult rat brain slices. Synapse, 3:331-335.
4. Aghajanian, G.K., and Wang, Y.-Y. (1986) Pertussis toxin blocks the outward currents evoked by opiate and a2-agonists in locus coeruleus neurons. Brain Res., 371:390-394.
5. Aghajanian, G.K., and Wang, Y.-Y. (1987) Common a2- and opiate effector mechanisms in the locus coeruleus: Intracellular studies in brain slices. Neuropharmacology, 26:793-799.
6. Andrade, R., and Aghajanian, G.K. (1984) Locus coeruleus activity in vitro: Intrinsic regulation by a calcium-dependent potassium conductance but not alpha-2 adrenoceptors. J. Neurosci., 4:161-170.
7. Andrade, R., Vandermaelen, C.P., and Aghajanian, G.K. (1983) Morphine tolerance and dependence in the locus coeruleus: Single cell studies in brain slices. Eur. J. Pharmacol., 91:161-169.
8. Bhargava, H.N. (1978) Quantification of morphine tolerance induced by pellet implantation in the rat. J. Pharm. Pharmacol., 30:133-135.
9. Bird, S.J., and Kuhar, M.J. (1977) Iontophoretic application of opiates to the locus coeruleus. Brain Res., 122:523-533.
10. Blasig, J., Hertz, A. , Reinhold, K., and Zieglgansberger, S. (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia (Berl.), 33:19-38.
11. Bredt, D.S., and Snyder, S.H. (1992) Nitric oxide, a novel neuronal messenger. Neuron, 8:3-11.
12. Charney, D.S., Sternberg, D.E., Kleber, H.D., Heninger, G.R., and Redmond, D.E. Jr. (1981) The clinical use of clonidine in abrupt withdrawal from methadone. Arch. Gen. Psychiat, 38:1273-1277.
13. Christie, M.J., Williams, J.T., and North, R.A. (1987) Cellular mechanisms of opioid tolerance: Studies in single brain neurons. Mol. Pharmacol., 32:633-638.
14. DeLean, A., Munson, P.J., and Rodbard, D. (1978) Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235:E97-E102.
15. Duman, R.S., Tallman, J.F., and Nestler, E.J. (1988) Acute and chronic opiate-regulation of adenylate cyclase in brain: Specific effects in locus coeruleus. J. Pharmacol. Exp. Ther., 246:1033-1039.
16. Dwyer, M.A., Bredt, D.S., and Snyder, S.H. (1991) Nitric oxide synthase: Irreversible inhibition by L-Ng-nitroarginine in brain in vitro and in vivo. Biochem. Biophys. Res. Comm., 176:1136-1141.
17. Fiorillo, C.D., and Williams, J.T. (1996) Opioid desensitization: Interactions with G-protein-coupled receptors in the locus coeruleus. J. Neurosci., 16:1479-1485.
18. Gold, M.S., Redmond, D.E. Jr., and Kleber, H.D. (1978) Clonidine blocks opiate withdrawal. Lancet, 2:929-930.
19. Grant, S.J., and Highfield, D.A. (1991) Extracellular characteristics of putative Ch6 cholinergic neurons in the laterodorsal tegmental nucleus. Brain Res., 559:64-74.
20. Grant, S.J., Huang, Y.H., and Redmond, D.E. Jr. (1988) Behavior of monkeys during opiate withdrawal and locus coeruleus stimulation. Pharmacol. Biochem. Behav., 30:13-19.
21. Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns R.E., and Chaudhuri G. (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA, 84:9265-9269.
22. Kimes, A.S., and London, E.D. (1989) Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal. J. Pharmacol. Exp. Ther., 248:538-545.
23. Kimes, A.S., Vaupel, D.B., and London, E.D. (1993) Nitric oxide in opioid withdrawal: Attenuation of some withdrawal signs by inhibitors of nitric oxide synthase. Psychopharmacology, 112:521-524.
24. Kolesnikov, Y.A., Pick, C.G., and Pasternak, G.W. (1992) NG-nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmacol., 221:399-400.
25. Korf, J., Bunney, B.S., and Aghajanian, G.K. (1974) Noradrenergic neurons: Morphine inhibition of spontaneous activity. Eur. J. Pharmacol., 25:165-169.
26. Maldonado, R., and Koob, G.F. (1993) Destruction of the locus coeruleus decreases physical signs of withdrawal. Brain Res., 605:128-138.
27. Maldonado, R., Stinus, L., Gold, L.H., and Koob, L.H. (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther., 261:669-677.
28. Moore, P.K., Wallace, P., Gaffen, Z., Hart, S.L., and Babbedge, R.C. (1993) Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles - antinociceptive and cardiovascular effects. Br. J. Pharmacol., 110:219-224.
29. Nestler, E.J. (1992) Molecular mechanisms of drug addiction. J. Neurosci., 12:2439-2450.
30. Nestler, E.J., and Tallman, J.F. (1988) Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol., 33:127-132.
31. Nestler, E.J., Erdos, J.J., Terwilliger, R., Duman, R.S., and Tallman, J. (1989) Regulation of G proteins by chronic morphine in the rat locus coeruleus. Brain Res., 476:230-239.
32. North, R.A., and Williams, J.T. (1985) On the potassium conductance increased by opiates in rat locus coeruleus neurones. J. Physiol., 364:265-280.
33. North, R.A., Williams, J.T., Surprenant, A., and Christie, M.J. (1987) Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc. Natl. Acad. Sci. USA, 84:5487-5491.
34. Pineda, J., Kogan, J.H., and Aghajanian, G.K. (1996) Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: Involvement of a non-selective cationic channel. J. Neurosci., 16:1389-1399.
35. Pitts, D.K., Kelland, M.D. Shen, R.Y., Freeman, A.S., and Chiodo, L.A. (1990) Statistical analysis of dose-response curves in extracellular electrophysiological studies of single neurons. Synapse, 5:281-293.
36. Rasmussen, K., and Aghajanian, G.K. (1989) Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: Attenuation by lesions of the nucleus paragigantocellularis. Brain Res., 505:346-350.
37. Rasmussen, K., Beitner-Johnson, D.E., Krystal, J.H., Aghajanian, G.K., and Nestler, E.J. (1990) Opiate withdrawal and the rat locus coeruleus: Behavioral, electrophysiological, and biochemical correlates. J. Neurosci., 10:2308-2317.
38. Taylor, J.R., Elsworth, J.D., Garcia, E.J., Grant, S.J., Roth, R.H., and Redmond, D.E. Jr. (1988) Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology, 96: 121-134.
39. Valentino, R.J., and Wehby, R.G. (1989) Locus coeruleus discharge characteristics of morphine-dependent rats: Effects of naltrexone. Brain Res., 488:126-134.
40. Vaupel D.B., Kimes, A.S., and London, E.D. (1995a) Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology, 118:361-368.
41. Vaupel D.B., Kimes, A.S., and London, E.D. (1995b) Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology, 13:315-322.
42. Vaupel, D.B., Kimes, A.S., and London, E.D. (1997) Further in vivo studies on attenuating morphine withdrawal: Isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur. J. Pharmacol., 324:11-20.
43. Villar, V.M., and Bhargava, H.N. (1992) Pharmacodynamics and kinetics of loss of tolerance and physical dependence on morphine induced by pellet implantation in the rat. Pharmacology, 45:319-328.
44. Wang, Y.-Y., and Aghajanian, G.K. (1987a) Intracellular GTPgS restores the ability of morphine to hyperpolarize rat locus coeruleus neurons after blockade by pertussis toxin. Brain Res., 436:396-401.
45. Wang, Y.-Y., and Aghajanian, G.K. (1987b) Excitation of locus coeruleus neurons by an adenosine 3′,5′-cyclic monophosphate-activated inward current: Extracellular and intracellular studies in rat brain slices. Synapse, 1:482-487.
46. Williams, J.T., and North, R.A. (1984) Opiate-receptor interactions on single locus coeruleus neurons. Mol. Pharmacol., 26:489-497.
47. Xu, X., Zhang, F., Hu, J., El-Fakahany, E.E., and Iadecola, C. (1993). Long lasting inhibition of brain nitric oxide synthesis systematic administration of nitro-L-arginine methyl ester. Neurosci. Abst., 19:1385.
48. Xu, Z-Q, Peribone, V. A., Zhang, X. Grillner, S., and Hokfelt, T. (1994). A functional role for nitric oxide in locus coeruleus: Immunohistochemicl and electrophysiological studies. Exp. Brain Res., 98:75-83.
49. Zhang, J., and Snyder, S.H. (1992) Nitric axide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc. Nat. Acad. Sci. USA, 89:9382-9385.